Home > News > Study: Nanoparticles to Deliver Therapy for Heaves in Horses
April 29th, 2012
Study: Nanoparticles to Deliver Therapy for Heaves in Horses
Abstract:
In a recent clinical study researchers at the equine clinic of the Department of Veterinary Medicine at Ludwig Maximilians University, Munich, Germany, designed a nanoscale molecule (called a nanoparticle) to deliver CpG-ODN, an immunostimulating DNA that has been shown to suppress allergies in humans, to horses. "CpG-ODN works by producing an anti-allergic and anti-inflammatory cytokine (IL 10) that modulates the immune system to 'switch away' from the allergy and inflammatory reaction," said researcher Heidrun Gehlen, PhD, DrMedVet, Dipl. ECEIM.
Source:
thehorse.com
Related News Press |
News and information
Simulating magnetization in a Heisenberg quantum spin chain April 5th, 2024
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Discoveries
Chemical reactions can scramble quantum information as well as black holes April 5th, 2024
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Utilizing palladium for addressing contact issues of buried oxide thin film transistors April 5th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||